119 related articles for article (PubMed ID: 22633306)
1. Prognostic value of serum tenascin-C levels on long-term outcome after acute myocardial infarction.
Sato A; Hiroe M; Akiyama D; Hikita H; Nozato T; Hoshi T; Kimura T; Wang Z; Sakai S; Imanaka-Yoshida K; Yoshida T; Aonuma K
J Card Fail; 2012 Jun; 18(6):480-6. PubMed ID: 22633306
[TBL] [Abstract][Full Text] [Related]
2. Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction.
Sato A; Aonuma K; Imanaka-Yoshida K; Yoshida T; Isobe M; Kawase D; Kinoshita N; Yazaki Y; Hiroe M
J Am Coll Cardiol; 2006 Jun; 47(11):2319-25. PubMed ID: 16750702
[TBL] [Abstract][Full Text] [Related]
3. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
[TBL] [Abstract][Full Text] [Related]
4. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure.
Fujimoto N; Onishi K; Sato A; Terasaki F; Tsukada B; Nozato T; Yamada T; Imanaka-Yoshida K; Yoshida T; Ito M; Hiroe M
J Card Fail; 2009 Dec; 15(10):898-905. PubMed ID: 19944367
[TBL] [Abstract][Full Text] [Related]
5. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.
Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M
Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
8. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty.
Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Huczek Z; Horszczaruk GJ; Kochman J; Rudowski R; Opolski G
Am Heart J; 2004 Oct; 148(4):655-62. PubMed ID: 15459597
[TBL] [Abstract][Full Text] [Related]
9. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis.
Suzuki S; Yoshimura M; Nakayama M; Mizuno Y; Harada E; Ito T; Nakamura S; Abe K; Yamamuro M; Sakamoto T; Saito Y; Nakao K; Yasue H; Ogawa H
Circulation; 2004 Sep; 110(11):1387-91. PubMed ID: 15353502
[TBL] [Abstract][Full Text] [Related]
10. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
[TBL] [Abstract][Full Text] [Related]
12. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
[TBL] [Abstract][Full Text] [Related]
13. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
[TBL] [Abstract][Full Text] [Related]
14. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G
Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415
[TBL] [Abstract][Full Text] [Related]
15. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
[TBL] [Abstract][Full Text] [Related]
16. The inability of B-type natriuretic protein to predict short-term risk of death or myocardial infarction in non-heart-failure patients with marginally increased troponin levels.
Hubbard BL; Newton CR; Carter PM; Fowler JJ; Schaldenbrand J; Singal B; Cowen ME
Ann Emerg Med; 2010 Nov; 56(5):472-80. PubMed ID: 20363529
[TBL] [Abstract][Full Text] [Related]
17. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
Barthélémy O; Beygui F; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J; Montalescot G;
Am J Cardiol; 2009 Oct; 104(7):904-9. PubMed ID: 19766754
[TBL] [Abstract][Full Text] [Related]
18. In-hospital prognostic value of admission plasma B-type natriuretic peptide levels in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction.
Oduncu V; Erkol A; Tanalp AC; Dündar C; Tanboğa IH; Sırma D; Karagöz A; Karabay CY; Izgi A; Pala S; Tigen K; Kırma C
Turk Kardiyol Dern Ars; 2011 Oct; 39(7):540-8. PubMed ID: 21983763
[TBL] [Abstract][Full Text] [Related]
19. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J
Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.
de Lemos JA; Morrow DA; Bentley JH; Omland T; Sabatine MS; McCabe CH; Hall C; Cannon CP; Braunwald E
N Engl J Med; 2001 Oct; 345(14):1014-21. PubMed ID: 11586953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
